Related Experiment Video
Updated: Jun 26, 2026
06:31
Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Changes in the expression of claudins in active ulcerative colitis
Tadayuki Oshima1, Hiroto Miwa, Takashi Joh
1Department of Internal Medicine and Bioregulation, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. t-oshima@hyo-med.ac.jp
Journal of Gastroenterology and Hepatology
|January 6, 2009
Summary
In ulcerative colitis (UC), rectal epithelial tight junction proteins claudin-4 and -7 are down-regulated, while claudin-2 is up-regulated, potentially impairing gut barrier function.
Area of Science:
- Gastroenterology
- Cell Biology
- Molecular Biology
Background:
- Epithelial barrier dysfunction is a hallmark of ulcerative colitis (UC).
- The precise mechanisms underlying this barrier defect remain unclear.
- Tight junctions (TJs) are crucial for regulating epithelial barrier integrity.
Purpose of the Study:
- To investigate the expression of key tight junction proteins in the rectal mucosa of patients with active UC.
- To determine if alterations in TJ protein expression correlate with impaired epithelial barrier function in UC.
Main Methods:
- Rectal biopsies from active UC patients and controls were analyzed.
- Immunofluorescence microscopy was used to assess TJ protein localization.
- Immunoblotting and real-time PCR quantified TJ protein and mRNA levels for claudin-1, -2, -3, -4, and -7.
Main Results:
- Claudin-4 and -7 expression (protein and mRNA) were significantly down-regulated in active UC.
- Claudin-2 expression (protein and mRNA) was significantly up-regulated in active UC.
- Claudin-1 and -3 expression remained unchanged between active UC and control groups.
Conclusions:
- Altered expression of claudin-2, -4, and -7 in the rectal epithelium may contribute to TJ disruption.
- These molecular changes are potentially linked to the impaired epithelial barrier function observed in active UC.
More Related Videos
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...